dalteparin has been researched along with Diabetes, Gestational in 1 studies
Dalteparin: A low-molecular-weight fragment of heparin, prepared by nitrous acid depolymerization of porcine mucosal heparin. The mean molecular weight is 4000-6000 daltons. It is used therapeutically as an antithrombotic agent. (From Merck Index, 11th ed)
Diabetes, Gestational: Diabetes mellitus induced by PREGNANCY but resolved at the end of pregnancy. It does not include previously diagnosed diabetics who become pregnant (PREGNANCY IN DIABETICS). Gestational diabetes usually develops in late pregnancy when insulin antagonistic hormones peaks leading to INSULIN RESISTANCE; GLUCOSE INTOLERANCE; and HYPERGLYCEMIA.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Shi, Y | 1 |
| Qian, J | 1 |
| Zhang, F | 1 |
| Jia, B | 1 |
| Liu, X | 1 |
| Hu, Y | 1 |
| Zhang, Q | 1 |
| Yang, Y | 1 |
| Sun, D | 1 |
| Jiang, L | 1 |
1 other study available for dalteparin and Diabetes, Gestational
| Article | Year |
|---|---|
Low molecular weight heparin (nadroparin) improves placental permeability in rats with gestational diabetes mellitus via reduction of tight junction factors.
Topics: Animals; Diabetes, Gestational; Disease Models, Animal; Female; Glycation End Products, Advanced; Na | 2020 |